VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) was up 4.8% during mid-day trading on Tuesday . The company traded as high as C$0.22 and last traded at C$0.22. Approximately 30,500 shares traded hands during mid-day trading, a decline of 69% from the average daily volume of 98,865 shares. The stock had previously closed at C$0.21.
VentriPoint Diagnostics Stock Up 4.8 %
The business has a 50-day moving average price of C$0.25 and a 200-day moving average price of C$0.24. The company has a market capitalization of C$34.50 million, a price-to-earnings ratio of -7.33 and a beta of 0.39. The company has a quick ratio of 6.67, a current ratio of 2.06 and a debt-to-equity ratio of 32.61.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model that generates accurate heart volumetric measurements.
Featured Articles
- Five stocks we like better than VentriPoint Diagnostics
- What is a Secondary Public Offering? What Investors Need to Know
- Silicon Motion Proves That AI in Motion Stays in Motion
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Undervalued UnitedHealth Group Won’t Be For Long
- Why Are Stock Sectors Important to Successful Investing?
- The 5 Stocks Most Sold By Insiders This Year
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
